Price T Rowe Associates Inc Accelerate Diagnostics, Inc Transaction History

Price T Rowe Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.46 - $0.77 $12,134 - $20,312	-26,380 Reduced 29.22%	63,900 $45,000
Q2 2022 Aug 15, 2022	BUY	$0.54 - $1.41 $24,694 - $64,480	45,731 Added 102.65%	90,280 $90,000
Q1 2022 May 16, 2022	BUY	$1.4 - $5.15 $36,680 - $134,930	26,200 Added 142.79%	44,549 $64,000
Q4 2021 Feb 14, 2022	BUY	$4.27 - $6.97 $13,663 - $22,304	3,200 Added 21.12%	18,349 $96,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $1,592 - $2,475	300 Added 2.02%	15,149 $88,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.23 $101,121 - $137,056	14,849 New	14,849 $120,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $111M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.